Raras
Buscar doenças, sintomas, genes...
Condrossarcoma mixoide extraesquelético
ORPHA:209916CID-10 · C49.9CID-11 · 2B50.YOMIM 612237DOENÇA RARA

Neoplasia maligna rara de tecidos moles, de diferenciação incerta, caracterizada pela presença de células semelhantes a condroblastos em um estroma mixóide e um padrão de crescimento multinodular. Os locais mais comuns de envolvimento são os tecidos moles profundos das extremidades, particularmente a coxa. Geralmente se apresenta como uma massa crescente de tecidos moles. Os pacientes podem ter sobrevida longa, mas recorrências locais e metástases ocorrem em aproximadamente metade dos casos. O local mais comum de metástase são os pulmões.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Neoplasia maligna rara de tecidos moles, de diferenciação incerta, caracterizada pela presença de células semelhantes a condroblastos em um estroma mixóide e um padrão de crescimento multinodular. Os locais mais comuns de envolvimento são os tecidos moles profundos das extremidades, particularmente a coxa. Geralmente se apresenta como uma massa crescente de tecidos moles. Os pacientes podem ter sobrevida longa, mas recorrências locais e metástases ocorrem em aproximadamente metade dos casos. O local mais comum de metástase são os pulmões.

Pesquisas ativas
3 ensaios
22 total registrados no ClinicalTrials.gov
Publicações científicas
441 artigos
Último publicado: 2026 Apr 3
Medicamentos
3 registrados
DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, PAZOPANIB

Tem tratamento?

3 medicamentos registrados
Ver detalhes, fases e interações →
DOXORUBICIN HYDROCHLORIDEDOXORUBICINPAZOPANIB

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.2
Europe
Início
Adult
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: C49.9
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Características mais comuns

Condrossarcoma
HP:0001442
2sintomas
Sem dados (2)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 2 características clínicas mais associadas, ordenadas por frequência.

CondrossarcomaChondrosarcoma
HP:0001442

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico441PubMed
Últimos 10 anos176publicações
Pico202225 papers
Linha do tempo
2026Hoje · 2026🧪 1998Primeiro ensaio clínico📈 2022Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

5 genes identificados com associação a esta condição. Padrão de herança: Not applicable.

EWSR1RNA-binding protein EWSPart of a fusion gene inAltamente restrito
FUNÇÃO

Binds to ssRNA containing the consensus sequence 5'-AGGUAA-3' (PubMed:21256132). Might normally function as a transcriptional repressor (PubMed:10767297). EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes

LOCALIZAÇÃO

NucleusCytoplasmCell membrane

MECANISMO DE DOENÇA

Ewing sarcoma

A highly malignant, metastatic, primitive small round cell tumor of bone and soft tissue that affects children and adolescents. It belongs to the Ewing sarcoma family of tumors, a group of morphologically heterogeneous neoplasms that share the same cytogenetic features. They are considered neural tumors derived from cells of the neural crest. Ewing sarcoma represents the less differentiated form of the tumors.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
278.5 TPM
Cérebro - Hemisfério cerebelar
273.8 TPM
Testículo
272.3 TPM
Baço
257.8 TPM
Cervix Endocervix
248.9 TPM
OUTRAS DOENÇAS (6)
Ewing sarcomaextraskeletal Ewing sarcomahistiocytoma, Angiomatoid fibrousextraskeletal myxoid chondrosarcoma
HGNC:3508UniProt:Q01844
NR4A3Nuclear receptor subfamily 4 group A member 3Part of a fusion gene inAltamente restrito
FUNÇÃO

Transcriptional activator that binds to regulatory elements in promoter regions in a cell- and response element (target)-specific manner. Induces gene expression by binding as monomers to the NR4A1 response element (NBRE) 5'-AAAAGGTCA-3' site and as homodimers to the Nur response element (NurRE) site in the promoter of their regulated target genes (By similarity). Plays a role in the regulation of proliferation, survival and differentiation of many different cell types and also in metabolism and

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
MECANISMO DE DOENÇA

Ewing sarcoma

A highly malignant, metastatic, primitive small round cell tumor of bone and soft tissue that affects children and adolescents. It belongs to the Ewing sarcoma family of tumors, a group of morphologically heterogeneous neoplasms that share the same cytogenetic features. They are considered neural tumors derived from cells of the neural crest. Ewing sarcoma represents the less differentiated form of the tumors.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
41.6 TPM
Adipose Visceral Omentum
35.6 TPM
Ovário
31.6 TPM
Coração - Átrio
21.7 TPM
Fallopian Tube
16.6 TPM
OUTRAS DOENÇAS (1)
extraskeletal myxoid chondrosarcoma
HGNC:7982UniProt:Q92570
TCF12Transcription factor 12Part of a fusion gene inTolerante
FUNÇÃO

Transcriptional regulator. Involved in the initiation of neuronal differentiation. Activates transcription by binding to the E box (5'-CANNTG-3') (By similarity). May be involved in the functional network that regulates the development of the GnRH axis (PubMed:32620954)

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (5)
Negative Regulation of CDH1 Gene TranscriptionRUNX1 regulates transcription of genes involved in differentiation of HSCsNGF-stimulated transcriptionMyogenesisTGFBR3 expression
MECANISMO DE DOENÇA

Craniosynostosis 3

A primary abnormality of skull growth involving premature fusion of one or more cranial sutures. The growth velocity of the skull often cannot match that of the developing brain resulting in an abnormal head shape and, in some cases, increased intracranial pressure, which must be treated promptly to avoid permanent neurodevelopmental disability.

EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Endocervix
39.7 TPM
Cervix Ectocervix
38.1 TPM
Fibroblastos
37.1 TPM
Útero
32.3 TPM
Nervo tibial
28.4 TPM
OUTRAS DOENÇAS (4)
hypogonadotropic hypogonadism 26 with or without anosmiaTCF12-related craniosynostosisextraskeletal myxoid chondrosarcomaobsolete isolated brachycephaly
HGNC:11623UniProt:Q99081
TAF15Transcription initiation factor TFIID subunit 12Part of a fusion gene inAltamente restrito
FUNÇÃO

The TFIID basal transcription factor complex plays a major role in the initiation of RNA polymerase II (Pol II)-dependent transcription (PubMed:33795473). TFIID recognizes and binds promoters with or without a TATA box via its subunit TBP, a TATA-box-binding protein, and promotes assembly of the pre-initiation complex (PIC) (PubMed:33795473). The TFIID complex consists of TBP and TBP-associated factors (TAFs), including TAF1, TAF2, TAF3, TAF4, TAF5, TAF6, TAF7, TAF8, TAF9, TAF10, TAF11, TAF12 an

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (9)
Regulation of TP53 Activity through PhosphorylationRNA Polymerase II Promoter EscapeRNA Polymerase II HIV Promoter EscapeRNA Polymerase II Pre-transcription EventsHIV Transcription Initiation
EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
199.6 TPM
Testículo
191.9 TPM
Fibroblastos
180.0 TPM
Esôfago - Muscular
141.2 TPM
Útero
137.9 TPM
OUTRAS DOENÇAS (2)
extraskeletal myxoid chondrosarcomaamyotrophic lateral sclerosis
HGNC:11547UniProt:Q16514
TFGProtein TFGPart of a fusion gene inModerado
FUNÇÃO

Plays a role in the normal dynamic function of the endoplasmic reticulum (ER) and its associated microtubules (PubMed:23479643, PubMed:27813252). Required for secretory cargo traffic from the endoplasmic reticulum to the Golgi apparatus (PubMed:21478858)

LOCALIZAÇÃO

Endoplasmic reticulum

VIAS BIOLÓGICAS (1)
COPII-mediated vesicle transport
EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
86.6 TPM
Linfócitos
61.6 TPM
Tireoide
60.1 TPM
Nervo tibial
55.3 TPM
Aorta
53.8 TPM
OUTRAS DOENÇAS (5)
hereditary motor and sensory neuropathy, Okinawa typehereditary spastic paraplegia 57autosomal dominant Charcot-Marie-Tooth disease type 2 due to TFG mutationdifferentiated thyroid carcinoma
HGNC:11758UniProt:Q92734

Medicamentos e terapias

DOXORUBICIN HYDROCHLORIDEPhase 3

Mecanismo: DNA topoisomerase II alpha inhibitor

DOXORUBICINPhase 3

Mecanismo: DNA topoisomerase II alpha inhibitor

PAZOPANIBPhase 2

Mecanismo: Vascular endothelial growth factor receptor inhibitor

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

348 variantes patogênicas registradas no ClinVar.

🧬 TFG: NM_006070.6(TFG):c.317G>T (p.Arg106Leu) ()
🧬 TFG: NM_006070.6(TFG):c.829A>G (p.Ser277Gly) ()
🧬 TFG: NC_000003.11:g.(?_100428337)_(100438903_100447555)dup ()
🧬 TFG: NM_006070.6(TFG):c.273T>G (p.Asn91Lys) ()
🧬 TFG: GRCh38/hg38 3q11.1-21.2(chr3:93979547-124774010)x1 ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 2 variantes classificadas pelo ClinVar.

2
VUS (100.0%)
VARIANTES MAIS SIGNIFICATIVAS
NR4A3: NM_006981.4(NR4A3):c.1712G>A (p.Ser571Asn) [Uncertain significance]
TAF15: NM_139215.3(TAF15):c.305C>T (p.Ala102Val) [Uncertain significance]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 36
2Fase 211
1Fase 12
·Pré-clínico2
Medicamentos catalogadosEnsaios clínicos· 3 medicamentos · 18 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Condrossarcoma mixoide extraesquelético

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

22 ensaios clínicos encontrados, 3 ativos.

Distribuição por fase
NCT02180867 · Radiation Therapy With or Without Combination Chemotherapy o…Ativo
PHASE2, PHASE3
NCT05836571 · Testing Ipilimumab and Nivolumab Combination With or Without…Ativo
PHASE2
NCT06526897 · Evaluation of Chest CT Versus Chest X-Ray for Lung Surveilla…Em breve
NA
NCT03600649 · Clinical Trial of SP-2577 (Seclidemstat) in Patients With Re…UNKNOWN
PHASE1
NCT05266196 · A Rollover Protocol to Allow for Continued Access to the LSD…UNKNOWN
PHASE1, PHASE2
NCT02066285 · Trial of Pazopanib in Patients With Solitary Fibrous Tumor a…Concluído
PHASE2
NCT00346164 · Observation, Radiation Therapy, Combination Chemotherapy, an…Concluído
PHASE3
NCT01532687 · Gemcitabine With or Without Pazopanib in Treating Patients W…Concluído
PHASE2
NCT00423618 · Randomised Trial of Volume of Post-operative Radiotherapy Gi…Concluído
PHASE3
NCT00589121 · Image-Guided Radiation Therapy in Treating Patients With Pri…Concluído
PHASE2
NCT01154452 · Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhi…Concluído
PHASE1, PHASE2
NCT00112463 · Depsipeptide (Romidepsin) in Treating Patients With Metastat…Concluído
PHASE2
NCT00720174 · Cixutumumab and Doxorubicin Hydrochloride in Treating Patien…Concluído
PHASE1
NCT00474994 · Sunitinib in Treating Patients With Metastatic, Locally Adva…Concluído
PHASE2
NCT01189253 · Doxorubicin Hydrochloride or Trabectedin in Treating Patient…Encerrado
PHASE2, PHASE3
NCT00740597 · Intensity-Modulated Radiation Therapy in Treating Patients U…Encerrado
PHASE2
NCT00003718 · Temozolomide in Treating Patients With Advanced Soft Tissue …UNKNOWN
PHASE2
NCT00900211 · Tissue Sample Collection From Patients With Soft Tissue Sarc…UNKNOWN
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
178 papers (10 anos)
#1

Endovascular Thrombectomy in a Patient with Acute Ischemic Stroke due to Tumor Emboli Associated with Cardiac Metastasis of Extraskeletal Myxoid Chondrosarcoma: A Case Report.

NMC case report journal2026

Cardioembolic stroke caused by tumor emboli is a rare form of cancer-associated stroke. We report a case of a patient with cardiac metastasis of extraskeletal chondrosarcoma who developed left internal carotid artery occlusion due to embolic stroke. Extraskeletal chondrosarcoma is an extremely rare subtype of soft tissue sarcoma characterized by a tendency for local recurrence and metastasis. Endovascular thrombectomy was performed using a combined technique, achieving complete revascularization. Histopathological analysis of the retrieved cell mass confirmed that the embolic source was the preexisting extraskeletal chondrosarcoma.

#2

A series of extraskeletal myxoid chondrosarcomas with rare morphological and molecular variations.

Histopathology2026 Feb 26

Extraskeletal myxoid chondrosarcoma (EMC) is a rare soft tissue sarcoma characterised by myxoid matrix, multilobular architecture, eosinophilic ovoid to short spindle cells arranged in cords, clusters or reticular patterns and NR4A3 gene rearrangement. However, some EMCs show morphological variations or non-EWSR1::NR4A3 fusion. We described herein five cases of variant EMCs. The five patients included two females and three males, aged 24-59 years (median: 49 years). The tumours were located in the dorsal region, buttock, thigh, paravertebral region and elbow, respectively. Grossly, the tumour sizes ranged from 4.0 to 16.0 cm (median: 6.5 cm) in greatest dimension. Morphological examination revealed tumours with varied growth patterns, including solid variants with eosinophilic proteinaceous fluid (n = 2), classic EMC morphology with rhabdoid cells (n = 1), a biphasic variant, composed of fibroblastic/myofibroblastic-like cells and oval to short spindle-shaped cells (n = 1), and a spindle-cell morphology with a myxoid stroma and prominent haemorrhagic cystic spaces (n = 1). Immunohistochemically, all cases showed variable expression of CD117. Next-generation sequencing (NGS) identified an EWSR1::NR4A3 fusion, a novel FUS::NR4A2 fusion, a novel ACTB::NR4A3 fusion, and two FUS::NR4A3 fusions. Follow-up for all five patients showed no signs of local recurrence or distant metastasis. These five cases of EMC highlight the continuous morphological spectrum of this tumour, demonstrating significantly greater histological diversity than classically described. The identification of novel fusion partners further expands its genetic landscape.

#3

Reconstruction after unplanned excisions of soft tissue sarcomas using intraoperative extracorporeal autogenous irradiated bone and tendon grafts: a report of three cases.

World journal of surgical oncology2026 Feb 13

Wide resection of soft tissue sarcomas (STS) of the hand and foot is challenging due to limited soft tissue and complex anatomy. Reconstruction often requires tissue from healthy donor sites. To address this, we used intraoperative extracorporeal irradiation (ECI) of tumor-affected bones and tendons for reconstruction after wide resection. Herein, we report the oncological and functional outcomes using this technique. Three patients who underwent unplanned excision of the hand or foot at another institution referred to our hospital for additional treatment. Case 1: A 46-year-old man with extraskeletal myxoid chondrosarcoma on the dorsal aspect of the left hand underwent wide resection followed by ECI bone and extensor tendon reconstruction with free flap coverage, and subsequently required tenolysis. At 5 years, he showed no recurrence and excellent function (Musculoskeletal tumor society (MSTS) score, 100%; Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) score, 20.5). Case 2: A 27-year-old woman with synovial sarcoma of the dorsal right hand underwent wide resection and ECI bone and extensor tendon reconstruction. Delayed bone union required secondary bone grafting. She remained disease-free at 6 years with mild functional impairment (MSTS, 80%; QuickDASH, 29.5). Case 3: A 19-year-old woman with synovial sarcoma of the dorsal aspect of the right hallux underwent en bloc resection and ECI bone and extensor tendon reconstruction. At 4 years, she had no recurrence and excellent functional recovery (MSTS, 97%). Reconstruction using ECI-treated autogenous bone and tendon grafts allows effective oncological resection while preserving limb function and avoiding donor-site morbidity. Although mild degenerative changes were observed after osteoarticular reconstruction, all patients reported satisfactory outcomes and returned to their occupations. ECI is a valuable limb-salvage reconstruction option for STS of the hands and feet.

#4

[Clinicopathological and molecular characteristics of extraskeletal myxoid chondrosarcoma: an analysis of sixteen cases].

Zhonghua bing li xue za zhi = Chinese journal of pathology2026 Feb 08

Objective: To investigate the clinicopathological features, molecular characteristics and differential diagnosis of extraskeletal myxoid chondrosarcoma (EMC). Methods: A total of 16 cases of EMC diagnosed from January 2016 to February 2025 were collected from Luoyang Orthopedic-Traumatological Hospital of Henan Province (Henan Provincial Orthopedic Hospital, 3 cases) and Beijing Jishuitan Hospital, Capital Medical University (13 cases) for clinicopathological, immunohistochemical, fluorescence in situ hybridization (FISH) and next generation sequencing analyses and follow-up. Results: There were 11 males and 5 females, with a median age of 51(30, 73) years. The tumor sites included extremities (n=12), trunk (n=3), and sacrum (n=1). Histologically, EMC showed two distinct subtypes. Fourteen cases (14/16) were classic subtype with pale-blue myxoid or chondromyxoid matrix. The cells characteristically interconnected with one another to form cords, small clusters, and complex trabecular or cribriform patterns. The tumor cells were round, ovoid, short spindle or star-shaped; some may be rhabdoid with eosinophilic cytoplasm and eccentrically placed nuclei. Two cases were cellular subtype, demonstrating solid sheets of epithelioid cells with minimal intervening myxoid matrix, large vesicular nuclei, prominent nucleoli, and brisk mitotic activity. Immunohistochemistry showed that the cells diffusely or partially expressed vimentin, CD117, Syn, INSM-1, CD34, SMA and NSE, but were negative for pan-keratin (AE1/AE3), S-100, calponin, desmin and brachyury. INI1 expression was not deleted. The proliferation index of Ki-67 ranged from 2% to 15% in the classic subtype and 5% in the cellular subtype. NR4A3 gene rearrangement was detected by FISH in 15 cases (15/16), and EWSR1::NR4A3 fusion was confirmed by next-generation sequencing in 4 cases. Follow-up data were available in 14 patients (1-104 months), of whom 7 (7/14) developed local recurrence and 2 (2/14) developed distant metastases. Conclusions: EMC is a rare mesenchymal malignancy that arises not only in soft tissues but also in bone. The predominant histological subtype is classical EMC, with a minority presenting as cell-rich EMC. FISH detection of NR4A3 gene rearrangements provides a crucial value for the diagnosis. It needs to be differentiated from myoepithelial tumors, chordomas and myxoid liposarcomas. 目的: 探讨骨外黏液样软骨肉瘤(extraskeletal myxoid chondrosarcoma,EMC)的临床病理学特征、分子特征及鉴别诊断。 方法: 收集河南省洛阳正骨医院(河南省骨科医院,3例)及首都医科大学附属北京积水潭医院(13例)2016年1月至2025年2月确诊的16例EMC患者,分析其临床资料、组织病理学特点、免疫组织化学标志物表达情况及分子病理学特征,并进行随访。 结果: 16例患者中男性11例,女性5例,年龄51(30,73)岁。12例发生于四肢,3例发生于躯干,1例发生于骶骨。EMC呈分叶状生长,组织学形态可分为2种类型。14例(14/16)为经典型,丰富的黏液背景下较一致的圆形、卵圆形、短梭形或星形细胞稀疏排列,瘤细胞相互连接成索状、小梁状或网格状。瘤细胞也可呈横纹肌样,胞质嗜伊红核偏位。2例(2/16)为富细胞型,大部分区域瘤细胞丰富呈片状或实性排列,含有少量黏液样基质。瘤细胞上皮样、核呈空泡状,核仁明显,核分裂活跃。瘤细胞不同程度表达波形蛋白(15/15)、CD117(12/14)、突触素(6/13)、INSM-1(3/6),少数病例表达CD34、平滑肌肌动蛋白、神经元特异性烯醇化酶,INI1未缺失,广谱细胞角蛋白(AE1/AE3)、S-100蛋白、Calponin、结蛋白、brachyury均阴性,Ki-67阳性指数经典型为2%~15%,富细胞型约5%。15例荧光原位杂交检测到NR4A3基因重排(15/16),其中4例二代测序检测到EWSR1::NR4A3融合基因,1例(例13)同时检测到EWSR1基因和NR4A3基因断裂。14例获得随访,随访时间1~104个月,7例(7/14)出现局部复发,2例(2/14)远处转移。 结论: 骨外黏液样软骨肉瘤是一种罕见的间叶性恶性肿瘤,除发生于软组织外,也可发生于骨。病理组织学类型主要为经典型,少数为富细胞型。FISH法检测NR4A3基因重排对诊断具有重要价值。需与软组织肌上皮瘤、脊索瘤、黏液样脂肪肉瘤等鉴别。.

#5

A Case Report of a Patient Presenting With Extra-skeletal Myxoid Chondrosarcoma.

Cureus2026 Jan

Extra-skeletal myxoid chondrosarcoma (EMC) is a type of rare sarcoma of uncertain differentiation. This malignancy is marked by the growth of primitive chondroid cells forming multiple nodules within a rich myxoid matrix. It is distinguished by a specific translocation resulting in the fusion gene EWSR1::NR4A3, which is a distinctive molecular hallmark of EMC. EMC is categorised as an intermediate-grade tumour and is distinguished by a prolonged clinical course with a high likelihood of local recurrence and distant metastasis. Surgical treatment is the only option for a cure for EMC, while non-surgical treatments are typically considered for recurrent or distant disease. This case report discusses an interesting case of a patient with EMC and further elaborates on the history, examination, imaging, pathological findings, and management of EMC.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC281 artigos no totalmostrando 175

2026

Endovascular Thrombectomy in a Patient with Acute Ischemic Stroke due to Tumor Emboli Associated with Cardiac Metastasis of Extraskeletal Myxoid Chondrosarcoma: A Case Report.

NMC case report journal
2026

A series of extraskeletal myxoid chondrosarcomas with rare morphological and molecular variations.

Histopathology
2026

Reconstruction after unplanned excisions of soft tissue sarcomas using intraoperative extracorporeal autogenous irradiated bone and tendon grafts: a report of three cases.

World journal of surgical oncology
2026

[Clinicopathological and molecular characteristics of extraskeletal myxoid chondrosarcoma: an analysis of sixteen cases].

Zhonghua bing li xue za zhi = Chinese journal of pathology
2026

A Case Report of a Patient Presenting With Extra-skeletal Myxoid Chondrosarcoma.

Cureus
2026

Primary intracranial extraskeletal myxoid chondrosarcoma in a teenager with unusual frontal location and surgical complications: A case report and literature review.

Oncology letters
2025

Excellent Response and Persistent Local Control of Metastatic Extraskeletal Myxoid Chondrosarcoma Repeatedly Treated with Surgical Excision or Stereotactic Radiotherapy Alone: A Case Report.

Case reports in oncology
2025

Spontaneous regression of metastatic disease after palliative debulking surgery for heavily pre-treated extraskeletal myxoid chondrosarcoma: A case report.

Rare tumors
2025

Novel HSPA8-NR4A2 rearrangement in extraskeletal myxoid chondrosarcoma: a sarcoma mimicker of neuroendocrine neoplasia.

Virchows Archiv : an international journal of pathology
2025

Incidence and prognostic impact of regional lymph node metastasis at the time of diagnosis in soft-tissue sarcoma : a population-based cohort study.

The bone &amp; joint journal
2026

Clinical and magnetic resonance imaging features of soft tissue extraskeletal myxoid chondrosarcoma: A retrospective observational cohort study.

Skeletal radiology
2025

From pathogenesis to the patient's bedside: a comprehensive review of extraskeletal myxoid chondrosarcoma.

Journal of cancer research and clinical oncology
2025

Resection of Primary Lesion for Patients With Metastatic Soft Tissue Sarcoma at Initial Presentation.

Anticancer research
2025

The role of radiotherapy and chemotherapy in extraskeletal myxoid chondrosarcoma.

Journal of orthopaedic surgery and research
2025

Secondary Genetic Alterations in Extraskeletal Myxoid Chondrosarcoma.

Genes, chromosomes &amp; cancer
2025

Extraskeletal Myxoid Chondrosarcoma With Rhabdoid Features in a Pediatric Patient.

Cureus
2025

Establishment and characterization of NCC-EMC1-C1: a novel patient-derived cell line of extraskeletal myxoid chondrosarcoma.

Human cell
2025

Extraskeletal myxoid chondrosarcoma mimicking mucinous ovarian cancer: A case report.

The journal of obstetrics and gynaecology research
2025

Non-myxoid solid variant of extraskeletal myxoid chondrosarcoma: An underrecognized subtype.

Human pathology
2025

Laparoscopic-Assisted, Percutaneous Cryoablation: A Novel Technique for the Treatment of Abdominal Wall Soft Tissue Tumors.

Annals of surgical oncology
2025

Clinical, imaging and pathological features of extraskeletal myxoid chondrosarcoma.

Skeletal radiology
2023

Whole genome sequencing for metastatic mutational burden in extraskeletal myxoid chondrosarcoma.

Frontiers in molecular medicine
2024

Primary pulmonary myxoid sarcoma in the interlobar fissure of the left lung lobe: a case report.

BMC pulmonary medicine
2024

[Detection of EWSR1 gene rearrangement by fluorescence in situ hybridization in bone and soft tissue tumors: clinical application evaluation and atypical signal analysis].

Zhonghua bing li xue za zhi = Chinese journal of pathology
2024

Extraskeletal myxoid chondrosarcoma metastasis to a Meckel's diverticulum adenocarcinoma.

Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia
2024

FDG PET/CT and MRI Findings of Extraskeletal Myxoid Chondrosarcoma Showing a Nonmyxoid Cellular Variant.

Clinical nuclear medicine
2024

CHRNA6 RNA In Situ Hybridization Is a Useful Tool for the Diagnosis of Extraskeletal Myxoid Chondrosarcoma.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2024

Extraskeletal Myxoid Chondrosarcoma of Floor of Mouth-A Rare Case Report and Review of Literature.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India
2024

Identification of Novel/Rare EWSR1 Fusion Partners in Undifferentiated Mesenchymal Neoplasms.

International journal of molecular sciences
2024

18 F-FDG PET/CT Findings of Ovarian Myxoid Chondrosarcoma.

Clinical nuclear medicine
2024

Corrigendum to "Juxta-articular extraskeletal myxoid chondrosarcoma mistaken for a benign cyst presenting with multiple lung metastases" [Radiology Case Reports 19 (2024) 684-690].

Radiology case reports
2023

Extraskeletal myxoid chondrosarcoma of the buttock: a case report and literature review.

Frontiers in oncology
2024

Juxta-articular extraskeletal myxoid chondrosarcoma mistaken for a benign cyst presenting with multiple lung metastases.

Radiology case reports
2024

SMARCB1/INI1-deficient epithelioid and myxoid neoplasms in paratesticular region: Expanding the clinicopathologic and molecular spectrum.

Annals of diagnostic pathology
2023

Extraskeletal Myxoid Chondrosarcoma Identified in a Traumatic Fracture of the Toe: A Case Report.

Journal of orthopaedic case reports
2023

Extraskeletal myxoid chondrosarcoma of the gingival: a rare case report and review of the literature.

Diagnostic pathology
2023

Extraskeletal myxoid chondrosarcoma: a case report.

The Pan African medical journal
2023

PRAME immunohistochemistry in soft tissue tumors and mimics: a study of 350 cases highlighting its imperfect specificity but potentially useful diagnostic applications.

Virchows Archiv : an international journal of pathology
2023

Extraskeletal Myxoid Chondrosarcoma of the Jugular Foramen in a Pediatric Patient: A Case Report and Comprehensive Review of the Literature.

Pediatric neurosurgery
2023

TAF15::NR4A3 gene fusion identifies a morphologically distinct subset of extraskeletal myxoid chondrosarcoma mimicking myoepithelial tumors.

Genes, chromosomes &amp; cancer
2023

EWSR1::NR4A3 gene fusion in a cutaneous atypical myoepithelial neoplasm.

Journal of cutaneous pathology
2023

Extraskeletal Myxoid Chondrosarcomas: The Uncommon Clinicopathologic Manifestations and Significance of TAF15::NR4A3 Fusion.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2023

Extraskeletal Myxoid Chondrosarcoma: Retrospective Case Series Examining Prognostic Factors, Treatment Approaches, and Oncologic Outcomes.

American journal of clinical oncology
2023

Keratin-positive fibrotic extraskeletal myxoid chondrosarcoma: a close mimic of myoepithelial tumour.

Histopathology
2023

Extraskeletal myxoid chondrosarcoma in the pelvis successfully treated with proton beam radiotherapy.

BMJ case reports
2023

Extraskeletal Myxoid Chondrosarcoma of the Vulva: A Case Report.

Cureus
2023

A nonsteroidal anti-inflammatory drug, zaltoprofen, inhibits the growth of extraskeletal chondrosarcoma cells by inducing PPARγ, p21, p27, and p53.

Cell cycle (Georgetown, Tex.)
2022

Intra-muscular extraskeletal myxoid chondrosarcoma of the thigh: a case report.

International journal of clinical and experimental pathology
2022

Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a post-hoc analysis.

Frontiers in oncology
2023

Extraskeletal myxoid chondrosarcoma: A study of 17 cases focusing on the diagnostic utility of INSM1 expression and presenting rare morphological variants associated with non-EWSR1::NR4A3 fusions.

Human pathology
2023

Extraskeletal myxoid chondrosarcoma: p53 and Ki-67 offer prognostic value for clinical outcome - an immunohistochemical and molecular analysis of 31 cases.

Virchows Archiv : an international journal of pathology
2022

Surgical outcomes of extraskeletal myxoid chondrosarcoma.

Turkish journal of medical sciences
2023

Establishment, characterization and functional testing of two novel ex vivo extraskeletal myxoid chondrosarcoma (EMC) cell models.

Human cell
2022

[Cellular-rich extraskeletal myxoid chondrosarcoma: report of a case].

Zhonghua bing li xue za zhi = Chinese journal of pathology
2022

Identification of Novel PGR-NR4A3 Fusion in Extraskeletal Myxoid Chondrosarcoma and Resultant Patient Benefit From Tamoxifen Therapy.

JCO precision oncology
2022

Metastatic extraskeletal myxoid chondrosarcoma presenting as a forehead mass.

JAAD case reports
2022

Immunosuppressive tumor microenvironment in extraskeletal myxoid chondrosarcoma: A case of pleural metastases.

Thoracic cancer
2022

Extraskeletal myxoid chondrosarcoma: Clinicopathological features and outcomes from the United States sarcoma collaborative database.

Journal of surgical oncology
2023

A novel fusion variant LSM14A::NR4A3 in extraskeletal myxoid chondrosarcoma.

Genes, chromosomes &amp; cancer
2022

Case Report: Gene Heterogeneity in the Recurrent and Metastatic Lesions of a Myxoid Chondrosarcoma Patient With Aggressive Transformation.

Frontiers in genetics
2022

Musculoskeletal Tumors in Extremities Diagnosed During the Gestational Period: Case Series and Literature Review.

Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca
2022

Extraskeletal myxoid chondrosarcoma of the penis: Description of a rare tumor arising in an unusual location.

Urology case reports
2022

Differential diagnosis of myxoid soft tissue tumors. Experience in the Clinical University Hospital of Valencia.

Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia
2022

Primary extraskeletal myxoid chondrosarcoma of the breast: report of a case and literature review.

Pathologica
2022

Magnetic Resonance Imaging of Unusual Neoplasms Related to Foramen of Luschka: A Review for Differential Diagnosis.

The Indian journal of radiology &amp; imaging
2022

Primary intracranial extraskeletal myxoid chondrosarcoma: A case report and review of literature.

World journal of clinical cases
2022

GRM1 Immunohistochemistry Distinguishes Chondromyxoid Fibroma From its Histologic Mimics.

The American journal of surgical pathology
2022

High-dose-rate interstitial brachytherapy as a suitable option for metastatic extraskeletal myxoid chondrosarcoma - a case report.

Journal of contemporary brachytherapy
2022

Mutation of KIT in cellular extraskeletal myxoid chondrosarcoma: a case report and literature review.

Diagnostic pathology
2022

Extraskeletal myxoid chondrosarcoma: A case series and review of the literature.

Rare tumors
2022

Extraskeletal myxoid chondrosarcoma: A rare but important differential of a retroperitoneal mass.

Journal of medical imaging and radiation oncology
2022

Extraskeletal myxoid chondrosarcoma: Clinical features and overall survival.

Cancer treatment and research communications
2022

Analysis of clinicopathologic features and expression of NR4A3 in sinonasal acinic cell carcinoma.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2021

Intracranial Extraskeletal Myxoid Chondrosarcoma in Fourth Ventricle.

Brain tumor research and treatment
2022

Clinical Activity of Single-Agent Cabozantinib (XL184), a Multi-receptor Tyrosine Kinase Inhibitor, in Patients with Refractory Soft-Tissue Sarcomas.

Clinical cancer research : an official journal of the American Association for Cancer Research
2022

Fine-needle aspiration cytopathology of soft tissue myoepithelioma: an analysis of seven cases.

Journal of the American Society of Cytopathology
2021

Periosteal Myxoid Leiomyosarcoma Histologically Mimicking Extraskeletal Myxoid Chondrosarcoma: Report of a Case with Histopathological and Cytopathological Comparison with Extraskeletal Myxoid Chondrosarcoma.

Acta cytologica
2021

Primary intracranial extra-skeletal myxoid chondrosarcoma of right lateral ventricle with EWSR1 gene fusion: a case report and review of literature.

Ecancermedicalscience
2021

Anti-Hu-mediated paraneoplastic chronic intestinal pseudo-obstruction associated with extraskeletal myxoid chondrosarcoma.

Revista espanola de enfermedades digestivas
2021

A rare case of vulvar extraskeletal myxoid chondrosarcoma: mimics and diagnostic clues.

Autopsy &amp; case reports
2021

Sustained response to imatinib in patient with extraskeletal myxoid chondrosarcoma and novel KIT mutation.

BMJ case reports
2021

[Clinicopathological and molecular features of small round cell sarcoma of bone and soft tissue: a study of 72 cases].

Zhonghua bing li xue za zhi = Chinese journal of pathology
2021

Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations. Spanish Group for Sarcoma research (GEIS -GROUP). Part II.

Cancer treatment reviews
2022

Novel RGAG1-BCOR gene fusion revealed in a somatic soft tissue sarcoma with a long follow-up.

Virchows Archiv : an international journal of pathology
2021

Bone and soft tissue sarcomas in cerebrospinal fluid and effusion: A 20-year review at our institution.

Cancer cytopathology
2021

SMARCA2-NR4A3 is a novel fusion gene of extraskeletal myxoid chondrosarcoma identified by RNA next-generation sequencing.

Genes, chromosomes &amp; cancer
2021

Wide en bloc resection of an extraskeletal myxoid chondrosarcoma about the knee with single-stage knee extensor mechanism reconstruction: A case report.

The Knee
2021

Myxoepithelioid tumour with chordoid features: a clinicopathological, immunohistochemical and genetic study of 14 cases of SMARCB1/INI1-deficient soft-tissue neoplasm.

Histopathology
2020

Extraskeletal myxoid chondrosarcoma: a case report with adjuvant intraoperative treatment.

Journal of surgical case reports
2020

Locally recurrent extraskeletal myxoid chondrosarcoma of the shoulder: a case of complete neoadjuvant radiotherapy response.

Clinical sarcoma research
2020

Detection of Structural Variants in Circulating Cell-Free DNA from Sarcoma Patients Using Next Generation Sequencing.

Cancers
2021

Extraskeletal Myxoid Chondrosarcoma of the Vulva Confirmed by EWSR1 FISH: A Case Report and Review of the Literature.

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
2020

Extraskeletal Myxoid Chondrosarcoma: State of the Art and Current Research on Biology and Clinical Management.

Cancers
2020

Extraskeletal Myxoid Chondrosarcoma: Long-Term Survival in the Setting of Metastatic Disease.

Case reports in orthopedics
2021

Relevance of the combination of external beam radiotherapy with the hypoxia-activated prodrug ICF05016 in an experimental model of extraskeletal myxoid chondrosarcoma.

Investigational new drugs
2020

Curability of patients with lymph node metastases from extremity soft-tissue sarcoma.

Cancer
2020

Long-term Outcomes for Extraskeletal Myxoid Chondrosarcoma: A SEER Database Analysis.

Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
2021

Extraskeletal myxoid chondrosarcoma: combining cytopathology with molecular testing to achieve diagnostic accuracy.

Journal of the American Society of Cytopathology
2020

Extraskeletal myxoid chondrosarcoma: A high incidence of metastatic disease to lymph nodes.

Journal of surgical oncology
2021

SWI/SNF complex-deficient soft tissue neoplasms: An update.

Seminars in diagnostic pathology
2020

Extraskeletal Myxoid Chondrosarcoma: Clinical and Molecular Characteristics and Outcomes of Patients Treated at Two Institutions.

Frontiers in oncology
2020

ASO Author Reflections: Extraskeletal Myxoid Chondrosarcoma: A Rare Sarcoma Associated With Prolonged Survival.

Annals of surgical oncology
2021

Extraskeletal Myxoid Chondrosarcoma with Molecularly Confirmed Diagnosis: A Multicenter Retrospective Study Within the Italian Sarcoma Group.

Annals of surgical oncology
2020

Apatinib for Treatment of Inoperable Metastatic or Locally Advanced Chondrosarcoma: What We Can Learn About the Biological Behavior of Chondrosarcoma from a Two-Center Study.

Cancer management and research
2020

Design, synthesis and evaluation of targeted hypoxia-activated prodrugs applied to chondrosarcoma chemotherapy.

Bioorganic chemistry
2020

The Extracompartmental Tumoral Invasion of Extraskeletal Myxoid Chondrosarcoma Induces Distant Metastasis.

Anticancer research
2019

Ewing's sarcoma/peripheral primitive neuroectodermal tumor with extraskeletal myxoid chondrosarcoma-like areas: a case report.

International journal of clinical and experimental pathology
2019

Extraskeletal Myxoid Chondrosarcoma of the Parotid Gland.

Annals of maxillofacial surgery
2019

Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Sarcoma: A Multicenter, Retrospective Study.

Sarcoma
2020

A renal cell carcinoma with EWSR1-TFE3 fusion gene.

Genes, chromosomes &amp; cancer
2019

Extraskeletal Myxoid Chondrosarcoma of the Midfoot Presenting as Charcot Arthropathy: A Case Report.

JBJS case connector
2020

Results of a prospective phase 2 study of pazopanib in patients with surgically unresectable or metastatic chondrosarcoma.

Cancer
2019

NR4A3 Immunohistochemistry Lacks Sensitivity for the Diagnosis of Extraskeletal Myxoid Chondrosarcoma.

The American journal of surgical pathology
2019

Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial.

The Lancet. Oncology
2019

NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas.

The Journal of pathology
2019

EWSR1-NFATC2 Translocation-associated Sarcoma Clinicopathologic Findings in a Rare Aggressive Primary Bone or Soft Tissue Tumor.

The American journal of surgical pathology
2019

Extraskeletal myxoid chondrosarcoma of the leg in a child: A case report.

Medicine
2019

A 5-year follow-up of vulval swelling due to extraskeletal myxoid chondrosarcoma: A rare case report.

Molecular and clinical oncology
2018

Systemic manifestations of extraskeletal myxoid chondrosarcoma associated with a novel t(2;22)(q34;q12) EWS translocation in a child and a review of the literature.

Pediatric hematology and oncology
2019

SWI/SNF Complex-Deficient Soft Tissue Neoplasms: A Pattern-Based Approach to Diagnosis and Differential Diagnosis.

Surgical pathology clinics
2018

Extraskeletal myxoid chondrosarcoma with massive pulmonary metastases.

Clinical sarcoma research
2018

Fine-needle aspiration features of extraskeletal myxoid chondrosarcoma: A study of cytological and molecular features.

Diagnostic cytopathology
2019

Intraluminal EWSR1-CREB1 gene rearranged, low-grade myxoid sarcoma of the pulmonary artery resembling extraskeletal myxoid chondrosarcoma (EMC).

Histopathology
2018

Myxoid chondrosarcoma extraskeletal in pelvis location : a case report.

La Tunisie medicale
2018

Extraskeletal Chondrosarcoma: Long-term Follow-up of a Patient with Metastatic Disease.

Cureus
2018

Extraskeletal Myxoid Chondrosarcoma: A Comparative Study of Imaging and Pathology.

BioMed research international
2018

Identification of an Actionable Mutation of KIT in a Case of Extraskeletal Myxoid Chondrosarcoma.

International journal of molecular sciences
2018

Molecular and Clinicopathologic Heterogeneity of Intracranial Tumors Mimicking Extraskeletal Myxoid Chondrosarcoma.

Journal of neuropathology and experimental neurology
2018

[Primary extraskeletal myxoid chondrosarcoma of the corpus callosum: report of a case].

Zhonghua bing li xue za zhi = Chinese journal of pathology
2018

Myxoid and reticular angiomatoid fibrous histiocytoma: a case confirmed by fluorescence in situ hybridization analysis for EWSR1 rearrangement.

International journal of clinical and experimental pathology
2018

Comprehensive high-resolution genomic profiling and cytogenetics of human chondrocyte cultures by GTG-banding, locus-specific FISH, SKY and SNP array.

European cells &amp; materials
2018

Extraskeletal Myxoid Chondrosarcoma of Nasopharynx: An Oncologic Entity Rarely Reported.

Oman medical journal
2018

Extra-axial chordoma: a clinicopathologic analysis of six cases.

Virchows Archiv : an international journal of pathology
2018

Pre- and postoperative radiotherapy for extremity soft tissue sarcoma: Evaluation of inter-observer target volume contouring variability among French sarcoma group radiation oncologists.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
2017

Primary extraskeletal myxoid chondrosarcoma in cerebellum: A case report with literature review: Erratum.

Medicine
2017

Primary extraskeletal myxoid chondrosarcoma in cerebellum: A case report with literature review.

Medicine
2017

EWSR1-fusion-negative, SMARCB1-deficient primary pulmonary myxoid sarcoma.

Polish journal of pathology : official journal of the Polish Society of Pathologists
2018

INSM1 expression and its diagnostic significance in extraskeletal myxoid chondrosarcoma.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2017

Primary pulmonary myxoid sarcoma, a potential mimic of metastatic extraskeletal myxoid chondrosarcoma.

Pathology
2017

Clinical benefit of antiangiogenic therapy in advanced and metastatic chondrosarcoma.

Medical oncology (Northwood, London, England)
2017

Programmed Death Ligand 1 (PD-L1) Expression in Malignant Mesenchymal Tumors.

Turk patoloji dergisi
2017

[Histology-Specific Chemotherapy in Soft-Tissue Sarcomas].

Gan to kagaku ryoho. Cancer &amp; chemotherapy
2017

Extraskeletal myxoid chondrosarcoma of the masticator space in a pediatric patient.

Journal of clinical and experimental dentistry
2017

Claudin 6 expression is useful to distinguish myxofibrosarcomas from other myxoid soft tissue tumors.

Pathology, research and practice
2017

Next generation sequencing of extraskeletal myxoid chondrosarcoma.

Oncotarget
2017

HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcoma.

Genes, chromosomes &amp; cancer
2017

Curious case of extraskeletal myxoid chondrosarcoma.

Lung India : official organ of Indian Chest Society
2017

Primary extraskeletal myxoid chondrosarcoma of bone: Report of three cases and review of the literature.

Pathology, research and practice
2019

A rare manifestation of extraskeletal myxoid chondrosarcoma with a huge expanding hematoma.

Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association
2017

The spectrum of EWSR1-rearranged neoplasms at a tertiary sarcoma centre; assessing 772 tumour specimens and the value of current ancillary molecular diagnostic modalities.

British journal of cancer
2017

Unusual Signal Patterns of Break-apart FISH Probes Used in the Diagnosis of Soft Tissue Sarcomas.

Pathology oncology research : POR
2016

Diagnosis of extraskeletal myxoid chondrosarcoma in the thigh using EWSR1-NR4A3 gene fusion: a case report.

Journal of medical case reports
2018

Benefit of Radiotherapy in Extraskeletal Myxoid Chondrosarcoma: A Propensity Score Weighted Population-based Analysis of the SEER Database.

American journal of clinical oncology
2017

Extraskeletal Myxoid Chondrosarcoma of the Foot Clinically Mimicking Plantar Fibromatosis.

The American Journal of dermatopathology
2016

Myxoid chondrosarcoma of the mandible in a 22-year-old man: A case report.

Molecular and clinical oncology
2016

Pulmonary extraskeletal myxoid chondrosarcoma: A case report and literature review.

International journal of surgery case reports
2016

Results of sub-analysis of a phase 2 study on trabectedin treatment for extraskeletal myxoid chondrosarcoma and mesenchymal chondrosarcoma.

BMC cancer
2016

Clinicopathologic and radiologic features of extraskeletal myxoid chondrosarcoma: a retrospective study of 40 Chinese cases with literature review.

Annals of diagnostic pathology
2016

Extraskeletal myxoid chondrosarcoma of maxilla: A rare entity.

Journal of oral and maxillofacial pathology : JOMFP
2016

Extraskeletal Myxoid Chondrosarcoma of the Orbit.

Middle East African journal of ophthalmology
2016

Primary intra-articular sarcoma: a clinicopathological study of 15 cases.

Histopathology
2015

Unresectable Extraskeletal Myxoid Chondrosarcoma of the Neck: Early Tumor Response to Chemoradiotherapy.

Cureus
2015

Invasive urothelial carcinoma with chordoid features of the ureter: a rare entity and review of literature.

International journal of clinical and experimental pathology
2016

[Extraskeletal myxoid chondrosarcoma: a clinicopathologic analysis of seven cases].

Zhonghua bing li xue za zhi = Chinese journal of pathology
2015

Extraskeletal Myxoid Chondrosarcoma Presenting as a Plantar Fibroma: Case Report and Review of the Literature.

Anticancer research
2015

Paravertebral extraskeletal myxoid chondrosarcoma: a case report and review of the literature.

The Pan African medical journal
2015

Spontaneous Regression of Metastatic Extraskeletal Myxoid Chondrosarcoma.

The Annals of thoracic surgery
2016

The TFG-TEC oncoprotein induces transcriptional activation of the human β-enolase gene via chromatin modification of the promoter region.

Molecular carcinogenesis
2015

Breast Metastasis of Extraskeletal Myxoid Chondrosarcoma: A Case Report.

The American journal of case reports
2015

Soft tissue myoepithelial carcinoma with rhabdoid-like features and EWSR1 rearrangement: Fine needle aspiration cytology with histologic correlation.

Diagnostic cytopathology
2015

[Small cell type (Ewing-like) clear cell sarcoma of soft parts: a case report].

Ceskoslovenska patologie
2014

[Cardiac metastase of a soft tissue sarcoma: a case report and a review of the literature].

Revue medicale de Bruxelles
2014

Extraskeletal myxoid chondrosarcoma presenting as an intradural spinal mass: report of a rare clinical presentation with an emphasis on differential diagnostic considerations.

Rare tumors
2015

Primary extraskeletal myxoid chondrosarcoma of pulmonary arteries: a rare mimic of acute pulmonary thromboembolism.

Interactive cardiovascular and thoracic surgery
2014

Extraskeletal myxoid chondrosarcoma of the thigh in a child: a case report.

Journal of orthopaedic surgery (Hong Kong)
Ver todos os 281 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Condrossarcoma mixoide extraesquelético.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Condrossarcoma mixoide extraesquelético

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Endovascular Thrombectomy in a Patient with Acute Ischemic Stroke due to Tumor Emboli Associated with Cardiac Metastasis of Extraskeletal Myxoid Chondrosarcoma: A Case Report.
    NMC case report journal· 2026· PMID 41799218mais citado
  2. A series of extraskeletal myxoid chondrosarcomas with rare morphological and molecular variations.
    Histopathology· 2026· PMID 41755350mais citado
  3. Reconstruction after unplanned excisions of soft tissue sarcomas using intraoperative extracorporeal autogenous irradiated bone and tendon grafts: a report of three cases.
    World journal of surgical oncology· 2026· PMID 41689087mais citado
  4. [Clinicopathological and molecular characteristics of extraskeletal myxoid chondrosarcoma: an analysis of sixteen cases].
    Zhonghua bing li xue za zhi = Chinese journal of pathology· 2026· PMID 41644428mais citado
  5. A Case Report of a Patient Presenting With Extra-skeletal Myxoid Chondrosarcoma.
    Cureus· 2026· PMID 41635359mais citado
  6. Small Round Cell Tumors of Soft Tissue and Skeleton in Children and Youth: A Narrative and TruSight-Based Illustrative Review of Diagnostic Cases.
    Adv Anat Pathol· 2026· PMID 41930936recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:209916(Orphanet)
  2. OMIM OMIM:612237(OMIM)
  3. MONDO:0012825(MONDO)
  4. GARD:17105(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q18557267(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Condrossarcoma mixoide extraesquelético
Compêndio · Raras BR

Condrossarcoma mixoide extraesquelético

ORPHA:209916 · MONDO:0012825
Prevalência
1-9 / 1 000 000
Herança
Not applicable
CID-10
C49.9 · Neoplasia maligna do tecido conjuntivo e tecidos moles, não especificados
CID-11
Ensaios
3 ativos
Medicamentos
3 registrados
Início
Adult
Prevalência
0.2 (Europe)
MedGen
UMLS
C1275278
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades